日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Five-Year Analysis of the JULIET Trial of Tisagenlecleucel in Patients With Relapsed/Refractory Large B-Cell Lymphoma

JULIET试验中Tisagenlecleucel治疗复发/难治性大B细胞淋巴瘤患者的五年分析

Maziarz, Richard T; Bishop, Michael R; Tam, Constantine S; Borchmann, Peter; Worel, Nina; McGuirk, Joseph P; Holte, Harald; Waller, Edmund K; Jaglowski, Samantha; Andreadis, Charalambos; Foley, Stephen Ronan; Westin, Jason R; Fleury, Isabelle; Ho, P Joy; Mielke, Stephan; Teshima, Takanori; Janakiram, Murali; Hsu, Jingmei; Izutsu, Koji; Kersten, Marie José; Ghosh, Monalisa; Wagner-Johnston, Nina; Kato, Koji; Corradini, Paolo; Ma, Wanying; Han, Xia; Nuortti, Marja; Awasthi, Rakesh; Mundt, Kirsten E; Majdan, Marta; Maier, Harald J; Jegerlehner, Andrea; Salles, Gilles; Schuster, Stephen J

BrECADD vs BEACOPP and Health-Related Quality of Life in Advanced-Stage Hodgkin Lymphoma

BrECADD 与 BEACOPP 方案对晚期霍奇金淋巴瘤患者健康相关生活质量的影响

Ferdinandus, Justin; Müller, Horst; Jablonski, Janina; Kerkhoff, Andrea; Scholl, Sebastian; Ko, Yon-Dschun; Topp, Max S; Vucinic, Vladan; Jung, Wolfram; Schroers, Roland; Rank, Andreas; Fuchs, Michael; Schneider, Gundolf; Diehl, Volker; Borchmann, Peter; Behringer, Karolin

Long non-coding RNA <I>LINC00926</i> is a biomarker for naïve B-cells with prognostic value in advanced stage classic Hodgkin lymphoma

长链非编码RNA <I>LINC00926</i> 是幼稚B细胞的生物标志物,在晚期经典型霍奇金淋巴瘤中具有预后价值

Iaccarino, Ingram; Beder, Thomas; Reinke, Sarah; Borchmann, Peter; Von Tresckow, Bastian; Altenbuchinger, Michael; Klapper, Wolfram

Association between metabolic tumor burden and health-related quality of life in patients with classic Hodgkin lymphoma

经典霍奇金淋巴瘤患者代谢性肿瘤负荷与健康相关生活质量之间的关联

Lommen, Marie; Weindler, Jasmin J; Jablonski, Janina; Rosenbrock, Johannes; Borchmann, Peter; Behringer, Karolin; Roth, Katrin S; Ufton, Dominic; Dietlein, Markus; Kobe, Carsten; Ferdinandus, Justin

Rapid molecular response kinetics to anti-PD-1-based first-line treatment of Hodgkin lymphoma in the GHSG NIVAHL trial

GHSG NIVAHL试验中,基于抗PD-1的一线治疗霍奇金淋巴瘤的快速分子反应动力学

Heger, Jan-Michel; Mattlener, Julia; Herhaus, Peter; Meissner, Julia; Trautmann-Grill, Karolin; Voltin, Conrad-Amadeus; Schneider, Jessica; Schleifenbaum, Julia K; Heidenreich, Sophie; Kobe, Carsten; Kaul, Helen; Klapper, Wolfram; von Tresckow, Bastian; Borchmann, Peter; Bröckelmann, Paul J; Borchmann, Sven

Zamtocabtagene autoleucel in relapsed/refractory B-NHL: 5-year follow-up of a CD20/19 tandem CAR T-cell phase 1 trial

Zamtocabtagene autoleucel 治疗复发/难治性 B 细胞非霍奇金淋巴瘤:一项 CD20/19 串联 CAR T 细胞 I 期试验的 5 年随访结果

Balke-Want, Hyatt; Gödel, Philipp; Schmid, Christoph; Ayuk, Francis; Friedrichs, Birte; van Heteren, Pearl; Holtkamp, Silke; Zadoyan, Gregor; Brillant, Corinne; Costa, Joana; Hanssens, Linda; Holzer, Tatjana; Wöhle, Christian; Biedermann, Stefanie; Bürger, Iris; Orentas, Rimas; Overstijns, Toon; Scheid, Christoph; Holtick, Udo; Miltenyi, Stefan; Hallek, Michael; Borchmann, Peter; Kutsch, Nadine

Brentuximab vedotin monotherapy is a feasible and effective treatment for older patients with classical Hodgkin lymphoma unsuitable for curative chemotherapy: Results from the prospective GHSG-NLG phase II BVB trial

对于不适合接受根治性化疗的老年经典型霍奇金淋巴瘤患者,Brentuximab vedotin 单药治疗是一种可行且有效的治疗方法:来自前瞻性 GHSG-NLG II 期 BVB 试验的结果

Fosså, Alexander; Molin, Daniel; Bröckelmann, Paul J; Schneider, Gundolf; Schnetzke, Ulf; Linderoth, Johan; Kamper, Peter M H; Leppä, Sirpa M; Meissner, Julia; Schaub, Valdete; Lia, Kjersti; Fuchs, Michael; Borchmann, Peter; Böll, Boris

Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients

布伦妥昔单抗、环磷酰胺、多柔比星和泼尼松用于治疗老年晚期霍奇金淋巴瘤患者

Bröckelmann, Paul J; Böll, Boris; Molin, Daniel; Schneider, Gundolf; Leppä, Sirpa; Meissner, Julia; Kamper, Peter; Hutchings, Martin; Christensen, Jacob H; Schnetzke, Ulf; Fuchs, Michael; Jablonski, Janina; Eichenauer, Dennis A; von Tresckow, Bastian; Klapper, Wolfram; Kobe, Carsten; Borchmann, Peter; Fosså, Alexander

Serum TARC dynamics during anti-PD1-based first-line Hodgkin lymphoma treatment: An analysis from the GHSG NIVAHL trial

抗PD-1一线霍奇金淋巴瘤治疗期间血清TARC动态变化:来自GHSG NIVAHL试验的分析

Plattel, Wouter J; Teesink, Sophie; Visser, Lydia; Voltin, Conrad-Amadeus; Kaul, Helen; Schlößer, Hans A; Kroesen, Bart-Jan; Kobe, Carsten; von Tresckow, Bastian; Borchmann, Peter; Diepstra, Arjan; Bröckelmann, Paul J

Working towards harmonization of clinical trial reporting in Hodgkin lymphoma.

致力于霍奇金淋巴瘤临床试验报告的统一化

Kobe Carsten, Armand Philippe, Borchmann Sven, Collins Graham P, Cottereau Anne-Segolene, Ferdinandus Justin, Herrera Alex F, Rossi Davide, Plattel Wouter J, Barrington Sally F, Hutchings Martin